|
sweat gland disease
|
DOID_1383 |
|
|
skin cancer
|
DOID_4159 |
|
|
percent control
|
BAO_0000143 |
|
|
percent response
|
BAO_0000082 |
|
|
EC 1.14.99.9 (steroid 17alpha-monooxygenase) inhibitor
|
CHEBI_68640 |
|
|
EC 1.14.99.* (miscellaneous oxidoreductase acting on paired donors, with incorporation or reduction of molecular oxygen) inhibitor
|
CHEBI_76840 |
|
|
coupled enzyme activity measurement method
|
BAO_0000142 |
|
|
vulval Paget's disease
|
DOID_2097 |
|
|
vulva adenocarcinoma
|
DOID_2098 |
|
|
Luciferin 4-monooxygenase
|
BAO_0000141 |
|
|
oxidoreductase
|
BAO_0000291 |
|
|
adenocarcinoma
|
DOID_299 |
|
|
vulva carcinoma
|
DOID_1294 |
|
|
inversely correlated
|
BAO_0000140 |
|
|
antidiarrhoeal drug
|
CHEBI_55323 |
|
|
gastrointestinal drug
|
CHEBI_55324 |
|
|
mu-opioid receptor agonist
|
CHEBI_55322 |
|
|
opioid receptor agonist
|
CHEBI_60606 |
|
|
mu-opioid agent
|
CHEBI_60599 |
|
|
organism substance
|
UBERON_0000463 |
|
